A renoprotective effect of low dose losartan in patients with type 2 diabetes-Reference-Cited by-同舟云学术

A renoprotective effect of low dose losartan in patients with type 2 diabetes

Published:2008-01 Issue:1 Volume:79 Page:86-90
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Sawaki Hideaki,Terasaki Jungo,Fujita Atsushi,Nakagawa Seiko,Kanatsuna Norio,Sadahiro Katsuhiko,Isotani Haruhiko,Imagawa Akihisa,Hanafusa Toshiaki

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference21 articles.

1. US Renal Data System: USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2003.

2. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus;Valmadrid;Arch. Intern. Med.,2000

3. Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM;Forsblom;Diabetes Care,1998

4. Risk factors for microalbuminuria and macroalbuminuria in type 2 diabetic patients: a 9-year follow-up study;Murussi;Diabetes Care,2002

5. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study;Diabet. Med.,1999

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

2. Combining and converting groups when extracting data for meta-analysis;BMJ Evidence-Based Medicine;2021-02-08

3. Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials;Heart, Lung and Circulation;2018-06

4. Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension;Journal of the American Society of Hypertension;2016-01

5. Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment – systematic review and modelling of progression and cost-effectiveness;Health Technology Assessment;2014-02